Even though Northern California is the cradle for the technology industry, Silicon Valley has matured beyond the garages from which it was born. According to JLL’s 2015 United States Technology Office Outlook, technology firms and startups aren’t just exploring new U.S. markets, they’re starting to plant roots.
San Diego saw $43.8 billion in M&A transactions from 2011 through 2014. Large pharmaceutical companies are purchasing biotech firms to fill their R&D pipelines, rather than conduct R&D internally. San Diego has a strong R&D market… Read More
U.S. biopharmaceutical innovation is thriving, with areas like Boston, Raleigh-Durham and San Diego dominating U.S. life sciences activity. However, a scarcity of laboratory space is pushing biopharmaceutical companies to seek locations in suburban markets where space is available or can be constructed, while still providing proximity to talent and resources.
These trends, along with… Read More